Bretscher P A, Ogunremi O, Menon J N
Department of Microbiology, University of Saskatchewan, Saskatoon, Canada.
Behring Inst Mitt. 1997 Feb(98):153-9.
Infection of BALB/c mice with a standard and substantial number of Leishmania major parasites results in progressive disease, following the induction of a parasite-specific Th2 response. These mice have been designated as "susceptible" on this basis. We show that distinct types of immune response can be generated in "susceptible" BALB/c mice depending upon the number of parasites employed for infection, and that the pathophysiological consequences of such distinct responses are dramatically different. Infection with very low numbers of parasites results in the exclusive induction of a cell-mediated, Th1 response, and the generation of resistance to the standard and substantial challenge. Spleen cells from such resistant mice can confer resistance upon normal mice when transferred to them, but these spleen cells do not contain T cells expressing DTH or Th1 effector cells that produce IFN gamma on short term culture (48 hrs) with parasite antigen. The immune response in this case appears to result in the virtual elimination of parasites from the lymph node draining the site of infection and, by implication, from the infected mouse. We suggest that such elimination results in the absence of antigen stimulation and hence of effector T cells, and that "memory Th1 cells" are responsible for the capacity of spleen cells to confer resistance on normal mice. We predict such mice will not suffer parasitemia upon immune suppression, i.e. are not susceptible to reactivation disease. This is the "beneficial state". In contrast to this infection with a very low number of parasites infection with a low number usually results in one of two states: (i) The generation of a response with a very small Th2 component, production of a small amount of antibody, chronic parasitemia and hence chronic generation of parasite-specific effector Th1/Th2 cells, or (ii) The generation of a response with a greater Th2 component, the production of more antibody, the formation of a frank lesion, and the long term generation of a stable, mixed Th1/Th2 response. We refer to the latter state as borderline leishmaniasis in analogy with borderline leprosy. Parasites can be recovered from the draining lymph node in both these cases many months after infection. We therefore believe that mice infected with a low number of parasites, that harbour a chronic subclinical infection, will suffer reactivation disease upon immune suppression, and we consequently designate the state generated as potentially harmful. We consider mice with borderline disease to be in a harmful state. Mice immunised with high doses of parasite antigen produce in the long term Th2 responses, whereas those immunised with lower doses produce Th1 responses. Mice immunised to produce a Th2 response were subsequently infected with a very low number of parasites that is normally contained. The generation of a Th2 response results in the generation of a Th2 imprint, such that the response to the low dose infection is modulated from a Th1 to a Th2 mode, resulting in progressive disease. We argue that immunisation/vaccination, resulting in a state that deviates the protective response to a non-protective mode, may result in epidemics. Such a state has the potential for being extremely harmful.
用标准数量且数量可观的硕大利什曼原虫寄生虫感染BALB/c小鼠会导致疾病进展,这是在诱导出寄生虫特异性Th2反应之后。基于此,这些小鼠被认定为“易感”。我们发现,根据用于感染的寄生虫数量不同,“易感”的BALB/c小鼠会产生不同类型的免疫反应,而且这些不同反应的病理生理后果差异巨大。用极低数量的寄生虫感染会单独诱导出细胞介导的Th1反应,并产生对标准数量且数量可观的寄生虫攻击的抵抗力。来自这类抗性小鼠的脾细胞转移到正常小鼠后能使后者获得抗性,但这些脾细胞不含表达迟发型超敏反应(DTH)的T细胞或在与寄生虫抗原进行短期培养(48小时)时产生干扰素γ的Th1效应细胞。在这种情况下,免疫反应似乎会使感染部位引流淋巴结中的寄生虫几乎被清除,由此推断,感染小鼠体内的寄生虫也会被清除。我们认为这种清除导致抗原刺激消失,进而效应T细胞也消失,并且“记忆Th1细胞”是脾细胞能够赋予正常小鼠抗性的原因。我们预测这类小鼠在免疫抑制时不会出现寄生虫血症,即不易患再激活疾病。这就是“有益状态”。与用极低数量的寄生虫感染形成对比的是,用低数量的寄生虫感染通常会导致以下两种状态之一:(i)产生Th2成分非常少的反应,产生少量抗体,出现慢性寄生虫血症,从而长期产生寄生虫特异性效应Th1/Th2细胞;或者(ii)产生Th2成分更多的反应,产生更多抗体,形成明显病变,并长期产生稳定的混合Th1/Th2反应。我们将后一种状态称为边缘性利什曼病,类似于边缘性麻风病。在这两种情况下,感染数月后都能从引流淋巴结中分离出寄生虫。因此,我们认为用低数量的寄生虫感染并携带慢性亚临床感染的小鼠在免疫抑制时会患再激活疾病,所以我们将所产生的这种状态认定为潜在有害。我们认为处于边缘性疾病状态的小鼠处于有害状态。用高剂量寄生虫抗原免疫的小鼠长期产生Th2反应,而用低剂量免疫的小鼠产生Th1反应。免疫后产生Th2反应的小鼠随后用通常数量极低的寄生虫进行感染。Th2反应的产生会导致形成Th2印记,这样对低剂量感染的反应就会从Th1模式转变为Th2模式,从而导致疾病进展。我们认为免疫/接种疫苗导致保护反应偏离到非保护模式的状态可能会引发流行病。这种状态可能极其有害